Cerebral amyloid angiopathy, APP-related: genes and variants
Explore variant evidence for Cerebral amyloid angiopathy, APP-related across 1 analyzed protein (APP). Linked ClinVar records include 7 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-10. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Cerebral amyloid angiopathy, APP-related
APP: Amyloid-beta precursor protein
Its processing produces multiple fragments involved in neuronal biology, including amyloid-beta peptides generated by beta- and gamma-secretase cleavage. Increased amyloidogenic processing, pathogenic variants, or increased gene dosage can cause autosomal dominant Alzheimer disease or cerebral amyloid angiopathy.
7 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in APP have source records linked to Cerebral amyloid angiopathy, APP-related. Association strength is not clinical gene validity.
Where Cerebral amyloid angiopathy, APP-related variants cluster
- APP Transmembrane (positions 702–722): 3 of 6 ClinVar pathogenic / likely pathogenic variants, 18.3× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Cerebral amyloid angiopathy, APP-related
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| APP A713T | 713 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| APP V717I | 717 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| APP D694N | 694 | Extracellular | Pathogenic / likely pathogenic (★★) |
| APP E674Q | 674 | Extracellular | Pathogenic / likely pathogenic (★★) |
| APP E693Q | 693 | Extracellular | Pathogenic / likely pathogenic (★★) |
| APP L705V | 705 | Transmembrane | Pathogenic / likely pathogenic (★) |
| APP K687N | 687 | Extracellular | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Alzheimer disease also has ClinVar records linked to APP variants; they fall in the same places as the Cerebral amyloid angiopathy, APP-related variants (22 pathogenic / likely pathogenic).
- ABeta amyloidosis, Arctic type also has ClinVar records linked to APP variants; they fall partly in the same places as the Cerebral amyloid angiopathy, APP-related variants (3 pathogenic / likely pathogenic).
Diseases related to Cerebral amyloid angiopathy, APP-related
- Alzheimer disease, also linked to APP
- Dementia, also linked to APP
Frequently asked questions
Which genes have records linked to Cerebral amyloid angiopathy, APP-related?
This view contains 1 analyzed proteins: APP. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 7 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 19 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center